Index by author

October 01, 2005; Volume 72,Issue 10

  1. Adelstein, David

    1. A woman with headache and blurred vision
      Ena Segota, MD, David Adelstein, MD and Tarek Mekhail, MD, MSc
      Cleveland Clinic Journal of Medicine October 2005, 72 (10) 848-851;

      She has non-small-cell lung cancer and patchy symmetrical areas of subcortical edema in the posterior parietal and occipital lobes of the brain. What is the most likely diagnosis?

  2. Agatston, Arthur S.

    1. The end of the diet debates?
      Arthur S. Agatston, MD
      Cleveland Clinic Journal of Medicine October 2005, 72 (10) 946-950;

      The healthiest diet is a Mediterranean type that features foods that are high in omega-3 fatty acids, unsaturated fats, and fiber, and that have a low glycemic index.

  3. Almahameed, Amjad

    1. Managing abdominal aortic aneurysms Treat the aneurysm <em>and</em> the risk factors
      Managing abdominal aortic aneurysms Treat the aneurysm and the risk factors
      Amjad AlMahameed, MD, Ahmed Abdel Latif, MD and Linda M. Graham, MD
      Cleveland Clinic Journal of Medicine October 2005, 72 (10) 877-888;

      Abdominal aortic aneurysms are not only a danger in themselves, they also signify underlying vascular disease.

  4. Bilello, Kathryn Smith

    1. Respiratory tract infections: Another reason not to smoke
      Susan Murin, MD, MSc and Kathryn Smith Bilello, MD
      Cleveland Clinic Journal of Medicine October 2005, 72 (10) 916-920;

      Patients who smoke need to be informed about the benefits of being vaccinated and stopping smoking.

  5. Brescia, Gina R.

    1. Update in thrombosis: Answers to perplexing questions
      Daniel G. Federman, MD, Gina R. Brescia, MD, John P. Moriarty, MD, Sally G. Haskell, MD, Raj Krishnamurthy, MD and Robert S. Kirsner, MD, PhD
      Cleveland Clinic Journal of Medicine October 2005, 72 (10) 907-915;

      How long should patients receive warfarin? Is less-intense therapy as effective as standard therapy? When is the risk of recurrence highest? Do mutations increase the risk of recurrence?

  6. Dweik, Raed A.

    1. Pleural effusions: Evaluation and management
      José C. Yataco, MD and Raed A. Dweik, MD
      Cleveland Clinic Journal of Medicine October 2005, 72 (10) 854-872;

      A rational diagnostic workup will reveal the cause in most cases.

  7. Federman, Daniel G.

    1. Update in thrombosis: Answers to perplexing questions
      Daniel G. Federman, MD, Gina R. Brescia, MD, John P. Moriarty, MD, Sally G. Haskell, MD, Raj Krishnamurthy, MD and Robert S. Kirsner, MD, PhD
      Cleveland Clinic Journal of Medicine October 2005, 72 (10) 907-915;

      How long should patients receive warfarin? Is less-intense therapy as effective as standard therapy? When is the risk of recurrence highest? Do mutations increase the risk of recurrence?

  8. George, Susan

    1. Fever in a returned traveler
      Emil P. Lesho, DO, Susan George, MD and Glenn Wortmann, MD
      Cleveland Clinic Journal of Medicine October 2005, 72 (10) 921-927;

      Six weeks after returning from Manaus, Brazil, he has recurring symptoms of fever, nausea, vomiting, diarrhea, headache, and malaise. What is the likely diagnosis?

  9. Graham, Linda M.

    1. Managing abdominal aortic aneurysms Treat the aneurysm <em>and</em> the risk factors
      Managing abdominal aortic aneurysms Treat the aneurysm and the risk factors
      Amjad AlMahameed, MD, Ahmed Abdel Latif, MD and Linda M. Graham, MD
      Cleveland Clinic Journal of Medicine October 2005, 72 (10) 877-888;

      Abdominal aortic aneurysms are not only a danger in themselves, they also signify underlying vascular disease.

  10. Haskell, Sally G.

    1. Update in thrombosis: Answers to perplexing questions
      Daniel G. Federman, MD, Gina R. Brescia, MD, John P. Moriarty, MD, Sally G. Haskell, MD, Raj Krishnamurthy, MD and Robert S. Kirsner, MD, PhD
      Cleveland Clinic Journal of Medicine October 2005, 72 (10) 907-915;

      How long should patients receive warfarin? Is less-intense therapy as effective as standard therapy? When is the risk of recurrence highest? Do mutations increase the risk of recurrence?

« Previous (Pages : 1 2 3 ... 3) Next »
Back to top

In this issue